Does Rallies track congressional trades in ELAN?

Yes. Rallies tracks politician and congressional stock disclosures for ELAN, including reported purchases, sales, dates, owners, and trade amounts when available.

Is ELAN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ELAN. It does not provide personalized investment advice.

ELAN (Elanco Animal Health Incorporated Common Stock) Stock Analysis - Politician Trades

Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of May 21, 2026, ELAN trades at $20.80 with a market cap of $9.95B and a P/E ratio of -41.81. ELAN moved +5.25% today. Year to date, ELAN is -9.54%; over the trailing twelve months it is +59.40%. Its 52-week range spans $8.02 to $27.72. Analyst consensus is strong buy with an average price target of $29.18. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ELAN stock?

Recent politician trading activity in ELAN includes disclosures from Ro Khanna, Val Hoyle, Ro Khanna, Ro Khanna, and Dan Sullivan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

ELAN Key Metrics

Key financial metrics for ELAN
Metric	Value
Price	$20.80
Market Cap	$9.95B
P/E Ratio	-41.81
EPS	$-0.50
Dividend Yield	0.00%
52-Week High	$27.72
52-Week Low	$8.02
Volume	152
Avg Volume	0
Revenue (TTM)	$4.89B
Net Income	$-242.00M
Gross Margin	55.06%

Congressional Trades in ELAN

Ro Khanna sale ELAN on Oct 27, 2025 (amount: $15.00K).
Val Hoyle sale ELAN on Sep 23, 2025 (amount: $15.00K) for Spouse.
Ro Khanna purchase ELAN on Sep 26, 2024 (amount: $15.00K) for Spouse.
Ro Khanna sale ELAN on Jun 5, 2024 (amount: $15.00K) for Spouse.
Dan Sullivan sale ELAN on Nov 30, 2022 (amount: $15.00K) for Joint.

Latest ELAN News

Elanco jumps after Q1 beat and raised 2026 outlook on innovation momentum — May 6, 2026
Elanco jumps ahead of May 6 earnings, focus on guidance and innovation momentum — May 5, 2026
Elanco drops on FDA warning letter tied to Pradalex promotions ahead of Q1 report — Apr 27, 2026
Elanco slides 3% with no fresh headline as investors await Q1 earnings — Apr 23, 2026
Elanco slides 3% as traders de-risk ahead of Q1 report and key Befrena launch — Apr 21, 2026

Recent ELAN Insider Trades

Modi Rajeev A. bought 4.91K (~$99.94K) on May 15, 2026.
Simmons Jeffrey N bought 4.97K (~$99.84K) on May 15, 2026.

ELAN Analyst Consensus

12 analysts cover ELAN: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.18.

Common questions about ELAN

Which politicians traded ELAN stock?: Recent politician trading activity in ELAN includes disclosures from Ro Khanna, Val Hoyle, Ro Khanna, Ro Khanna, and Dan Sullivan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in ELAN?: Yes. Rallies tracks politician and congressional stock disclosures for ELAN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ELAN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ELAN. It does not provide personalized investment advice.